Logo

Schrodinger Expands its Drug Discovery Efforts Against COVID-19 Deploying Parallel Computing on Google Cloud

Share this

Schrodinger Expands its Drug Discovery Efforts Against COVID-19 Deploying Parallel Computing on Google Cloud

Shots:

  • Schrodinger expands its work to discover novel antiviral therapies for COVID-19 as a part of a philanthropic global initiative. The accelerated pace includes the evaluation of billions of molecules/ week and is supported by Google Cloud which provides its high-powered parallel computing enabling the rapid exploration of chemical space
  • Schrodinger has evaluated four different protein targets for the COVID-19 initiative and utilized Google Cloud to support ultra-large virtual screens for two targets
  • In early 2020- the two companies collaborated- providing Schrodinger access to computing capacity equivalent to the world’s most powerful supercomputers to accelerate discovery for its commercial partners and its internal pipeline

Click here to read full press release/ article | Ref: Business wire | Image: Fierce Biotech


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions